SEC Form 4 · accession 0000899243-16-023212
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francis E Odonnell Jr.
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 15, 2016 | J | 300,000 | — | D | 1,385,490 | I | By HCG II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The distribution was made to an unrelated member of Hopkins Capital Group II, LLC, who is not an affiliate of the issuer and for no consideration. The shares were transferred as restricted shares pursuant to Rule 144 and will require at least a six month holding period.
- F2The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.